BioStem Technologies, Inc. (BSEM)
OTCMKTS
· Delayed Price · Currency is USD
5.12
-0.09 (-1.73%)
Mar 9, 2026, 3:53 PM EST
BioStem Technologies Revenue
BioStem Technologies had revenue of $10.47M in the quarter ending September 30, 2025, a decrease of -43.12%. This brings the company's revenue in the last twelve months to $292.21M, up 399.02% year-over-year. In the year 2024, BioStem Technologies had annual revenue of $301.83M with 1,708.93% growth.
Revenue (ttm)
292.21M
Revenue Growth
+399.02%
P/S Ratio
0.30
Revenue / Employee
8.85M
Employees
33
Market Cap
87.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 301.83M | 285.14M | 1,708.93% |
| Dec 31, 2023 | 16.69M | 9.81M | 142.69% |
| Dec 31, 2022 | 6.88M | 2.53M | 58.38% |
| Dec 31, 2021 | 4.34M | 4.03M | 1,284.88% |
| Dec 31, 2017 | 313.45K | -293.78K | -48.38% |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
| Dec 31, 2010 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nuo Therapeutics | 2.61M |
| Vaxart | 148.20M |
| Arch Biopartners | 115.29K |
| ZIVO Bioscience | 209.03K |
| Harvard Apparatus Regenerative Technology | 743.00K |
| Silence Therapeutics | 559.00K |